🔎 Trials Near Me

Dachaigh › Melanoma › Virginia › Arlington

Sgrùdaidhean clionaigeach Melanoma ann an Arlington, VA

Tha 20 sgrùdaidhean airson Melanoma a’ lorg phàirtichean aig làraichean ann agus timcheall air Arlington (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

A’ fastadhÌre 1
  • Inova Schar Cancer Institute, Fairfax · 11 mìle air falbh
  • NEXT Virginia, Fairfax · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06270706

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

A’ fastadhÌre 2
  • Inova Schar Cancer Institute ( Site 4046), Fairfax · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06961006

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

A’ fastadhÌre 1
  • Inova Schar Cancer Infusion Pharmacy, Fairfax · 11 mìle air falbh
  • Inova Schar Cancer, Fairfax · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07519655

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

A’ fastadhÌre 3
  • Inova Schar Cancer Institute, Fairfax · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06246916

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

A’ fastadhÌre 2
  • Inova Fairfax Hospital, Falls Church · 4 mìle air falbh
  • Inova Schar Cancer Institute, Fairfax · 11 mìle air falbh
  • Inova Fair Oaks Hospital, Fairfax · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05136196

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Virginia Cancer Specialists-Fairfax, Fairfax · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT07287917

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

A’ fastadhÌre 1
  • Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT04913285

Project: Every Child for Younger Patients With Cancer

A’ fastadhSgrùdadh amharc
  • Inova Fairfax Hospital, Falls Church · 4 mìle air falbh
Suas gu aois 25 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT02402244

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

A’ fastadhÌre 1/2
  • Research Site, Fairfax · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT07115043

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Clinical Trial Site, Fairfax · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT07749586

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

A’ fastadhÌre 1/2
  • Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Lùna 2026 · NCT06330064

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

A’ fastadhÌre 1/2
  • Next Oncology Virginia, Fairfax · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Cèit 2026 · NCT05379985

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

A’ fastadhÌre 1
  • NEXT Oncology - Virginia, Fairfax · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Gibl 2026 · NCT06326411

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

A’ fastadhÌre 1
  • NEXT Virginia, Fairfax · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Faoi 2026 · NCT07317505

Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC

A’ fastadhÌre 1
  • NEXT Oncology, Fairfax · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Samh 2025 · NCT06332755

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

A’ fastadhÌre 1/2
  • Research Site 102, Fairfax · 11 mìle air falbh
  • Research Site 112, Fairfax · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Samh 2025 · NCT05914116

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

A’ fastadhÌre 1/2
  • Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Dàmh 2025 · NCT04370587

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

A’ fastadhÌre 1/2
  • Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Gearr 2025 · NCT05669430

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

A’ fastadhÌre 1/2
  • NEXT Virginia, Fairfax · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Faoi 2025 · NCT06090266

A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

A’ fastadhÌre 1
  • Next Oncology, Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Faoi 2024 · NCT05746897

Sgrùdaidhean Melanoma ann am bailtean eile

Sgrùdaidhean eile ann an Arlington

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.